KRAS and colorectal cancer: Using cross‐species validation from the largest yeast genetic interactome (Costanzo et al., 2010), we provide evidence of the novel role of KRAS signaling biology in upregulating HRR and as a potential therapeutic strategy in killing KRAS‐mutant colorectal cancer cells.